Controlled trial of azathioprine in chronic ulcerative colitis.
about
Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel diseaseImpact of thiopurines and anti-tumour necrosis factor therapy on hospitalisation and long-term surgical outcomes in ulcerative colitisOptimal management of steroid-dependent ulcerative colitisBone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.Defining quality indicators for best-practice management of inflammatory bowel disease in Canada.Drug therapy of ulcerative colitisAzathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration.Toward optimal use of corticosteroids in ulcerative colitis and Crohn's disease.Use of alpha-tocopherylquinone in the treatment of ulcerative colitis.Devastating diarrhoea caused by azathioprine: management difficulty in inflammatory bowel diseaseThe efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review.Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis.Drug management of ulcerative colitis.Randomised controlled trial of azathioprine withdrawal in ulcerative colitis.Immunosuppressive drugs in ulcerative colitis: twisting facts to suit theories?The long-term risk of continuous immunosuppression using thioguanides in inflammatory bowel diseaseThiopurines in inflammatory bowel disease revisitedProspective Evaluation of Pharmacogenomics and Metabolite Measurements upon Azathioprine Therapy in Inflammatory Bowel Disease: An Observational Study.Treatment of inflammatory bowel disease: a review of medical therapy.Current use of immunosuppressive agents in inflammatory bowel disease patients in East China.Are we giving azathioprine too much time?The impact of thiopurines on surgical outcomes in inflammatory bowel disease: do they make a difference?Medical treatment of ulcerative colitisSecond Korean guidelines for the management of ulcerative colitis.Medical treatment of ulcerative colitis.Standards for the use of ordinal scales in clinical trials.Long term results of use of azathioprine in patients with ulcerative colitis in India.Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told?Cytotoxic drugs for non-neoplastic disease.Is thiopurine therapy in ulcerative colitis as effective as in Crohn's disease?Therapeutic efficacy of azathioprine in addition to prednisone-based regimens as first-line chronic graft-versus-host disease treatment.Sustained Clinical Efficacy and Mucosal Healing of Thiopurine Maintenance Treatment in Ulcerative Colitis: A Real-Life StudyThe effect of pre-admission immunosuppression on colectomy rates in acute severe ulcerative colitis
P2860
Q24631869-F97ABB6D-5441-4901-9380-D48FEE58C6A2Q26771136-D748660B-87AC-4B6A-8AA5-7570913771E7Q26773203-DC773BB0-AFB4-4E07-B46A-DF5BEAEF8B62Q33492638-8F25F988-7540-4F5E-BA01-0CA258389BA2Q33725615-A4A81C85-3A0C-40E7-A2F4-F0B29790D8A4Q34403155-0FB7343B-A184-473A-88C2-35A6C96A952CQ34409942-D8BBF36E-6F7B-4536-B829-742C407CC297Q34495747-3006EB11-D064-45C1-BBBC-4C6AE9AC808AQ34529029-607B084D-5127-456C-926A-5F217760D445Q34530081-5F30DAF4-C0CE-4C3F-A607-607D729CE145Q34559065-31F90A15-E9C6-4B46-8B05-5DBFACC76DBBQ35760789-17F93355-87A6-424A-BBD9-EADA912EEB02Q35822286-45F61283-49E5-4AE4-AEA8-1BF837F6BC71Q35822294-C4221B2C-2606-4886-B2F4-2D0CA2E3EE2DQ36419073-0532FD8F-B175-41E4-9133-2E7AA3BC663EQ36443655-66B3F6DB-3715-44DD-8895-36CCBB9BFB48Q36715034-F517C0BC-8CB6-4FE9-AF76-D49831C57890Q36822402-90A65E02-2F35-4613-802D-5E686F848292Q37058862-4649768C-80EC-469C-ADFD-48CC51D98FDAQ37241970-099E7A2E-1796-42C3-84D5-61A1D7BE2D72Q37276966-235BCEFC-F7F5-4E15-97FF-64D39F0821ADQ37277894-027A6368-42A6-4E31-A08E-C543EE4DC523Q37427481-74D92921-F585-409C-AAF6-F1388039721AQ37662503-4AF295D5-F014-4900-9A88-ED077DAE17CCQ38938913-F235D5C6-D066-42C8-802E-8039210E3B93Q41360646-F5A3F801-25B9-4760-9E19-9D0DA3B3245AQ41824164-19DF82FD-B2CE-4851-A77A-A841FC7C333BQ42695266-A600B0F7-A72D-47B2-B0B0-0500AFCEDB8DQ42794738-2080FA12-5037-4B3B-B753-B762F5A21F04Q42844308-BD612467-D06A-4668-9734-A2CDB634894AQ49789358-D4C8AAFA-AF2F-430A-BF53-FAA8B4825F7EQ58585367-EB0B9CAC-4D4C-4297-B132-95613AEA8D7DQ59129235-3C4D6902-EB9A-4E78-BE7B-D907FE725A51
P2860
Controlled trial of azathioprine in chronic ulcerative colitis.
description
1982 nî lūn-bûn
@nan
1982 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1982 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
name
Controlled trial of azathioprine in chronic ulcerative colitis.
@ast
Controlled trial of azathioprine in chronic ulcerative colitis.
@en
Controlled trial of azathioprine in chronic ulcerative colitis.
@nl
type
label
Controlled trial of azathioprine in chronic ulcerative colitis.
@ast
Controlled trial of azathioprine in chronic ulcerative colitis.
@en
Controlled trial of azathioprine in chronic ulcerative colitis.
@nl
prefLabel
Controlled trial of azathioprine in chronic ulcerative colitis.
@ast
Controlled trial of azathioprine in chronic ulcerative colitis.
@en
Controlled trial of azathioprine in chronic ulcerative colitis.
@nl
P2860
P1433
P1476
Controlled trial of azathioprine in chronic ulcerative colitis.
@en
P2093
P2860
P304
P407
P577
1982-05-01T00:00:00Z